We are live on ! Find out more

9 hedge funds and large institutions have $3.05M invested in Daxor in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

331% more capital invested

Capital invested by funds: $707K → $3.05M (+$2.34M)

200% more funds holding

Funds holding: 3 → 9 (+6)

3.73% more ownership

Funds ownership: 1.24% → 4.97% (+3.7%)

Holders
9
Holders Change
+6
Holders Change %
+200%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DXR Hedge Fund Activity: Q3 2020 in Review

9 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q3 2020, worth a combined $3.05M — up 331% from $707K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new DXR positions and 0 closed out — a net gain of 6 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $2.07M.

  • 9 institutional investors held Daxor (DXR) as of Q3 2020, up from 3 in Q2 2020.
  • Funds reported $3.05M of Daxor stock for Q3 2020, up 331% quarter-over-quarter.
  • 6 funds opened new Daxor positions in Q3 2020 and 0 closed out, a net change of +6 holders.
  • The largest Daxor buyer in Q3 2020 was Sabby Management, an estimated $2.07M added.

Based on aggregated 13F filings for Q3 2020.